[HTML][HTML] Artificial intelligence (AI) and big data in cancer and precision oncology

Z Dlamini, FZ Francies, R Hull, R Marima - Computational and structural …, 2020 - Elsevier
Artificial intelligence (AI) and machine learning have significantly influenced many facets of
the healthcare sector. Advancement in technology has paved the way for analysis of big …

Heterogeneity in colorectal cancer: a challenge for personalized medicine?

C Molinari, G Marisi, A Passardi, L Matteucci… - International journal of …, 2018 - mdpi.com
High inter-patient variability and high spatial heterogeneity are features of colorectal cancer
(CRC). This may influence the molecular characterization of tumor tissue, now mandatory for …

[HTML][HTML] Unravelling the complexity of colorectal cancer: Heterogeneity, clonal evolution, and clinical implications

N Saoudi González, F Salvà, J Ros, I Baraibar… - Cancers, 2023 - mdpi.com
Simple Summary Metastatic colorectal cancer is a complex, prevalent, and life-threatening
disease influenced by various factors that affect its progression, evolution, and treatment …

[HTML][HTML] The liquid biopsy in the management of colorectal cancer: an overview

M Vacante, R Ciuni, F Basile, A Biondi - Biomedicines, 2020 - mdpi.com
Currently, there is a crucial need for novel diagnostic and prognostic biomarkers with high
specificity and sensitivity in patients with colorectal cancer. A “liquid biopsy” is characterized …

ALK (D5F3) CDx: an immunohistochemistry assay to identify ALK-positive NSCLC patients

H Uruga, M Mino-Kenudson - … and Personalized Medicine, 2018 - Taylor & Francis
Screening for anaplastic lymphoma kinase (ALK) rearrangements is a very important
process in treatment decision making for advanced non-small-cell lung cancer (NSCLC) …

Comprehensive tumor molecular profile analysis in clinical practice

M Özdoğan, E Papadopoulou, N Tsoulos… - BMC Medical …, 2021 - Springer
Background Tumor molecular profile analysis by Next Generation Sequencing technology is
currently widely applied in clinical practice and has enabled the detection of predictive …

[HTML][HTML] Clinical application of targeted deep sequencing in metastatic colorectal cancer patients: actionable genomic alteration in K-MASTER project

Y Lee, S Lee, JS Sung, HJ Chung… - … : Official Journal of …, 2021 - synapse.koreamed.org
Purpose Next-generation sequencing (NGS) can facilitate precision medicine approaches in
metastatic colorectal cancer (mCRC) patients. We investigated the molecular profiling of …

[HTML][HTML] Design and validation of a gene-targeted, next-generation sequencing panel for routine diagnosis in gliomas

N D'Haene, B Meléndez, O Blanchard, N De Nève… - Cancers, 2019 - mdpi.com
The updated 2016 World Health Organization (WHO) classification system for gliomas
integrates molecular alterations and histology to provide a greater diagnostic and prognostic …

[HTML][HTML] Development, implementation and assessment of molecular diagnostics by next generation sequencing in personalized treatment of cancer: experience of a …

J Simarro, R Murria, G Pérez-Simó, M Llop… - Cancers, 2019 - mdpi.com
The establishment of precision medicine in cancer patients requires the study of several
biomarkers. Single-gene testing approaches are limited by sample availability and …

MicroRNA-128 targeting RPN2 inhibits cell proliferation and migration through the Akt-p53-cyclin pathway in colorectal cancer cells

T Zhou, L Wu, Q Wang, Z Jiang, Y Li… - Oncology …, 2018 - spandidos-publications.com
Colorectal cancer (CRC) is a malignancy with high metastatic rates. The mechanism of miR-
128 on the regulation of Ribophorin-II (RPN2) in CRC cells was explored in the present …